Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 71335-2617

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 71335-2617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\users\ra\desktop\1.jpg (5a5eca60 Figure 01)

This text contains information related to blood pressure values and the medications used to control it. The medications mentioned are Valsartan-HCTZ 320/125 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. The blood pressure values provided are organized from baseline SBP (systolic blood pressure) ranges. It seems to be part of a study or evaluation regarding hypertension treatment.*

FDA Label Image

C:\users\ra\desktop\2.jpg (5a5eca60 Figure 02)

This is a list of blood pressure measurements and medications used in a study. It includes the baseline diastolic blood pressure (DBP) value of 105 mmHg. The medications mentioned are Valsartan-HCTZ 320/25 mg and Valsartan 320 mg along with Hydrochlorothiazide 25 mg. Additionally, there is a reference to a placebo. The text also includes specific blood pressure percentages and values but overall paints a picture of a study involving the evaluation of blood pressure values with medication interventions.*

FDA Label Image

C:\users\ra\desktop\3.jpg (5a5eca60 Figure 03)

This text is not readable.*

FDA Label Image

C:\users\ra\desktop\4.jpg (5a5eca60 Figure 04)

This appears to be a section referring to blood pressure readings and medication dosages. It includes information about Valsartan-Hydrochlorothiazide combination tablets and their individual dosages in milligrams. Additionally, there is a mention of placebo. The text also indicates a baseline diastolic blood pressure (DBP) measurement in millimeters of mercury (mmHg).*

FDA Label Image

C:\users\ra\desktop\5.jpg (5a5eca60 Figure 05)

FDA Label Image

C:\users\ra\desktop\6.jpg (5a5eca60 Figure 06)

FDA Label Image

Label (Lbl713352617)

Each tablet contains: 160 mg of Valsartan USP and 12.5 mg of Hydrochlorothiazide USP. This medication is intended for patients and is available in a container with 30 tablets. The recommended storage temperature is between 20°C to 25°C. Additional excursions in temperature are allowed within the range of 15°C to 30°C. The package insert includes essential information for patients, and QR code can be scanned for additional details. Note that this medication should be kept away from moisture and out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.